title: American Association for Cancer Research--96th Annual Meeting. Targeting the cell cycle and HDAC inhibitors.
authors.affiliation: Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London W1T 4JE, UK. tom.phillips@thomson.com
authors.forename: Tom
authors.initials: T
authors.lastname: Phillips
authors.forename: Tracey
authors.initials: T
authors.lastname: Collins
authors.forename: Jamie
authors.initials: J
authors.lastname: Davies
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D007262:Infusions, Intravenous; D008870:Microtubules / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000648:ultrastructure; D016615:Telomere / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors